← CASTLE BIOSCIENCES INC
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $22.8m |
$51.9m
+127.62%
|
$62.6m
+20.79%
|
$94.1m
+50.18%
|
$137.0m
+45.65%
|
$219.8m
+60.38%
|
$332.1m
+51.09%
|
$344.2m
+3.66%
|
$357.3m
+3.79%
|
|
| Cost of Revenue | $5.3m |
$7.3m
+38.00%
|
$9.7m
+32.49%
|
$15.8m
+63.37%
|
$32.0m
+102.31%
|
$45.0m
+40.53%
|
$60.2m
+33.84%
|
$71.0m
+17.98%
|
$81.3m
+14.39%
|
|
| Gross Profit | $17.5m |
$44.6m
+154.76%
|
$53.0m
+18.87%
|
$78.3m
+47.77%
|
$105.0m
+34.20%
|
$174.8m
+66.43%
|
$271.9m
+55.52%
|
$273.2m
+0.49%
|
$276.0m
+1.03%
|
|
| Research and Development Expense | $4.9m | $7.4m | $13.3m | $29.6m | $44.9m | $53.6m | $52.0m | $51.9m | $55.4m | |
| Selling, General and Administrative Expense | $16.5m | $29.8m | $48.1m | $86.7m | $143.0m | $180.2m | $200.0m | $229.3m | $243.7m | |
| Amortization of Intangible Assets | $36k | $4k | $0 | $2.0m | $8.3m | $9.0m | $11.1m | $34.8m | — | |
| Operating Expenses | $21.3m | $37.2m | — | — | — | — | — | — | $389.4m | |
| Operating Income (Loss) | ($3.8m) |
$7.3m
+291.03%
|
($6.5m)
-189.27%
|
($40.1m)
-512.64%
|
($72.9m)
-81.78%
|
($68.0m)
+6.70%
|
$8.7m
+112.75%
|
($42.8m)
-593.77%
|
($32.1m)
+25.00%
|
|
| Other Operating Income (Expense), Net | — | — | $1.9m | $0 | — | — | — | — | — | |
| Debt Securities, Realized Gain (Loss) | — | — | — | — | — | — | — | $0 | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | — | $484k | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | $0 | ($2.1m) | $0 | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($272k) | ($2.9m) | $0 | — | — | — | — | $144k | — | |
| Interest Expense (non-operating) | $2.3m | $4.6m | $2.6m | $1k | $17k | $11k | $577k | $86k | $375k | |
| Current Income Tax Expense (Benefit) | $9k | $72k | $84k | $16k | $111k | $324k | $1.9m | $872k | $212k | |
| Income Tax Expense (Benefit) | $9k | $72k | $84k | ($8.7m) | ($1.8m) | $101k | $3.3m | ($5.4m) | $212k | |
| Net Income (Loss) Attributable to Parent | ($6.4m) |
$5.3m
+182.88%
|
($10.3m)
-294.88%
|
($31.3m)
-204.28%
|
($67.1m)
-114.55%
|
($57.5m)
+14.41%
|
$18.2m
+131.75%
|
($24.2m)
-232.41%
|
($19.4m)
+19.63%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | ($10.2m) |
$3.0m
+129.43%
|
($10.3m)
-443.83%
|
— | — | — | — | — | ($19.4m) | |
| Earnings Per Share, Basic | ($5.33) | $0.35 | ($0.54) | ($1.24) | ($2.58) | ($2.14) | $0.66 | ($0.83) | ($0.64) | |
| Earnings Per Share, Diluted | ($5.33) | ($0.21) | ($0.54) | ($1.24) | ($2.58) | ($2.14) | $0.62 | ($0.83) | ($0.64) | |
| Common Stock, Dividends, Per Share, Declared | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 1.9m | 8.6m | 18.9m | 25.1m | 26.1m | 26.8m | 27.8m | 29.0m | 29.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.9m | 8.7m | 18.9m | 25.1m | 26.1m | 26.8m | 29.3m | 29.0m | 29.7m | |
| Additional Financial Items | ||||||||||
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | — | — | — | |
| Income (Loss) Attributable to Parent, before Tax | ($6.4m) | $5.3m | ($10.2m) | ($40.0m) | ($68.9m) | ($57.4m) | $21.6m | ($29.5m) | — |